Member Vetting Process
Log In
About
Members
News
Awards
Contact
Member Vetting Process
Log In
Log In
Member Search
Specialism
Law Firm
Advisory Firm
Country
Afghanistan
Albania
Algeria
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belgium
Belize
Bermuda
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
British Virgin Islands
Bulgaria
Cameroon
Canada
Cayman Islands
Chile
China
Colombia
Congo (Dem. Rep.)
Costa Rica
Croatia
Cyprus
Czech Republic
Denmark
Djibouti
Dominican Republic
Egypt
El Salvador
Estonia
Finland
France
Germany
Ghana
Gibraltar
Greece
Guatemala
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Israel
Italy
Jamaica
Japan
Jersey
Kenya
Korea (South)
Kosovo
Kuwait
Lebanon
Liechtenstein
Luxembourg
Macau
Macedonia
Madagascar
Malaysia
Malta
Mauritania
Mauritius
Mexico
Monaco
Morocco
Netherlands
New Zealand
Nicaragua
Nigeria
Norway
Pakistan
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Ireland
Romania
Russia
Saint Kitts and Nevis
Saint Lucia
Saudi Arabia
Senegal
Serbia
Seychelles
Singapore
Slovakia
Slovenia
South Africa
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Togo
Trinidad and Tobago
Tunisia
Turkey
Turks and Caicos Islands
UAE
Uganda
UK
Ukraine
Uruguay
USA
Vietnam
Zimbabwe
Practice Area
Abuse of Dominance
Accountancy
Accounting and Tax
Acquisition Finance
Administrative
Admiralty
Agribusiness
AI
Alternative Asset Management
Alternative Dispute Resolution
Alternative Finance
Arbitration
Art
Asset Protection
Asset Protection Structures
Audit & Assurance
Audit & Finance
Audit and Accounting Services
Audit and Administration
Aviation
Banking & Finance
Banking Litigation
Bankruptcy
Broker Risk Management
Business
Business Formation
Business Immigration
Capital Markets
Citizenship
Citizenship by Descent
Civil
Civil Litigation
Civil Rights
Commercial
Commercial Arbitration
Commercial Contracts
Commercial Leasing
Commercial Litigation
Commercial Litigation
Commercial Property
Commercial Real Estate
Commercial Tenancy
Commodities Trading
Commodity Disputes
Company
Company & Fund Administration
Company Formation
Competition
Compliance
Compliance & Regulatory
Construction
Contentious Probate
Contract
Contractual Disputes
Copyright
Corporate
Corporate Accountant & VAT
Corporate Criminal
Corporate Finance
Corporate Governance
Corporate Immigration
Corporate Investment
Corporate Restructuring
Corporate Risk Management
Corporate Services
Corporate Support Services
Corporate Tax
Costs
Criminal
Criminal Defence
Criminal Fraud
Cross Border Estates
Cross-Border
Cross-Border Transactions
Cultural Property
Customs Advisory
Data & Innovation
Data Privacy
Data Protection
Debt Collection
Debt Recovery
Defence & Security Procurement
Digital Transformation Consultancy
Dispute Resolution
Divorce
Domestic & International Tax
Due Diligence
Economic Criminal
Employee Benefits
Employment
Employment Litigation
Energy
Energy & Natural Resources
Environmental
ERISA & Employment Benefits
Estate Planning
European
Expert Witness Property Valuation
Family
Fiduciary
Financial Services
Financial Services & Regulatory
Financial Transactions
FinTech
Fiscal
Foreign Direct Investments
Foreign Investments
Franchise
Fraud
Full Service
Fund Administration
Gaming
Health & Safety
Healthcare
Healthcare M&A
Hedge Funds
Human Rights & Labour Rights
Immigration
India Desk
Industrial Relations
Information Technology
Infrastructure
Inheritance
Insolvency
Insurance
Insurance & Reinsurance
Insurance Litigation
Intellectual Property
International Arbitration
International Business
International Corporate
International Debt Collection
International Dispute Resolution
International Employment
International Franchise
International Fraud
International Litigation
International Private
International Real Estate
International Succession
International Tax
International Tax Planning
International Trade
International Trade & National Security
Investigations
Investment
IP Litigation
IT
IT Services
Joint Ventures
Labour & Employment
Leasehold Enfranchisement
Legal Malpractice
Legal Risk Management
Life Science Patent
Life Sciences
Litigation
Litigation & Arbitration
M&A
Maritime
Maritime Arbitration
Matrimonial
Media & Entertainment
Mediation
Mediation & Arbitration
Medical Malpractice
Mining
Neuroradiology Expert Witness
New Technologies
Oil & Gas
Orthopaedic Expert Witness
Patent Litigation
Patent Prosecution
Patents
Payroll Accounting
Personal Injury
Personal Injury - Plaintiff
Pharmaceutical Sector Patents
Pharmaceuticals & Life Sciences
Private Client
Private Equity
Private Funds
Probate & Inheritance
Products
Project
Project Finance
Property Valuation
Public Procurement
Real Estate
Real Estate - Property
Regulatory
Regulatory & Compliance
Renewable Energy
Restructuring
SaaS/PaaS
Securities
Securities Litigation
Shipping & Admiralty
Shipping & Maritime
Shipping Finance
Sports
Start Up
Succession
Tax
Tax Litigation
Tax Planning
Tax Relocation
Tax Services
Tax Structures
Technology
Telecommunications
TMT
Trademark
Transaction
Transfer Pricing
Transportation
Trust & Estates
Trust Administration
Venture Capital
Wealth & Estate Planning
Wealth Management
Wealth Planning
Whistleblower
White Collar Crime
Wills, Trusts & Estate Planning
Workers Compensation
Workplace Law & Investigations
Competition & COVID-19-CCI Issues Advisory for Businesses During COVID-19
Published: Monday, July 27, 2020
The fair trade regulator, the Competition Commission of India (“CCI”), has joined other peers across the Globe and has issued a brief advisory on 19 April 2020 for guidance of businessmen across sectors on whether limited coordination can be allowed to bridge demand and supply gap during the nationwide lockdown due to COVID 19 pandemic and if so to what extent.
The advisory published on the official website can be viewed
here
.
We provide below a gist of the DO’s & DON’T’s for benefit of our readers.
What you CAN DO during COVID-19:
1.You may
coordinate
certain activities in a limited way, by way of sharing data on stock levels, timings of operation, sharing of distribution network and infrastructure, transport logistics, R & D, production etc. to
ensure continued supply and fair distribution of products (e.g. medical and healthcare products such as ventilators, face masks, gloves, vaccines etc. and essential commodities) & services (e.g. logistics, testing etc.) during COVID-19
, provided such coordination does not lead to either price fixing, limiting or allocation of markets etc. as mentioned and prohibited under sub section 3 of section 3 of the Competition Act, 2002.
2.You may
enter into JOINT VENTURES
to undertake the above mentioned coordinated ventures to assist the government or the authorities concerned to fight the Corona Virus pandemic to ensure continued supply and fair distribution of products (e.g. medical and healthcare products such as ventilators, face masks, gloves, vaccines etc. and essential commodities) & services (e.g. logistics, testing etc.).
3.However, such JOINT VENTURES must be shown to lead to
efficiency gains
to escape any possible challenge thereof as an anti-competitive agreement to share, allocate or limit or control price, markets etc. The
increase in efficiency
must relate to efficiency in production, supply, distribution, storage, acquisition or control of goods or provision of services. Besides, it may also lead to the accrual of benefits to consumers; improvement in production or distribution of goods or provision of services; and promotion of technical, scientific and economic development by means of production or distribution of goods or provision of services.
What you CAN NOT DO during COVID-19
1.Any co-ordination with your competitors which may lead to either price fixing, limiting or allocation of markets etc. as mentioned and prohibited under sub section 3 of section 3 of the Competition Act, 2002.
2.Any co-ordination with your competitors which may be considered as DISPROPORTIONATE AND UNNECESSARY to address concerns arising from COVID-19. This may vary from case to case and will be considered on the facts and circumstances of each case.
3.Apart from any co-ordination with competitors or dealers considered necessary and proportionate to the requirement of meeting any emergency needs during the COVID-19 crisis, all other unilateral business conducts or market behaviour, by any firm with a large market share in the relevant markets, which may be considered either exploitative to consumers or exclusionary for smaller business rivals are and continue to be prohibited and may be penalized as abuse of dominant position under section 4 of the Act.
The CCI official advisory is just in time and a welcome step. It will be noticed that unlike the competition authorities of EU
1.
, CCI has not committed itself either against “active intervention” for “necessary and temporary” cooperation between competitors; or like those in the USA, has not carved out certain
categories of collaborations
2.
that may be permitted during the pandemic or like in the UK
3.
, or Holland, where exemption is granted to certain sectors by invoking relevant provision in the statute.
In our view, the approach taken by CCI is the right approach suited to the peculiar conditions in India because the existing legal framework in terms of assessing the appreciable adverse effect in competition (“
AAEC
”) under the Competition Act, 2002 (the Act) is flexible and enables the CCI, to undertake a case-by-case analysis taking into account any hardship/peculiarities of the present circumstances. The determination of AAEC requires a balancing of its procompetitive effects against its anticompetitive effects, mentioned specifically as factors under Section 19(3) of the Act. For instance, one of the factors that the CCI may consider while assessing the impact of an agreement is whether it enables or leads to
“improvements in production or distribution of goods or provision of service”
. Similarly, for determining the unliteral conduct of an enterprise with a strong market position to see whether an abuse of dominant position has occurred, requires the CCI to consider if an objective justifications exists that the enterprise had (such as, protecting the quality of supply chain, or meet competition) when imposing such restrictions.
MM Sharma
Head - Competition Law & Policy
Vaish Associates Advocates
E- mmsharma@vaishlaw.com
1.
The European Competition Network has confirmed that its competition authorities will not actively intervene against necessary and temporary measures put in place in order to avoid a shortage of supply during COVID 19. Available at -
https://ec.europa.eu/competition/ecn/202003_joint-statement_ecn_corona-crisis.pdf
2.
the Antitrust “Agencies” in USA i.e the Department of Justice (DOJ) and the Federal Trade Commission (FTC) in a joint statement have clarified that certain collaborative actions designed to improve the health and safety response to the current pandemic such as research and development activities, sharing of technical know-how, etc. will be considered consistent with the applicable antitrust laws. Available at -
https://www.ftc.gov/system/files/documents/public_statements/1569593/statement_on_coronavirus_ftc-doj-3-24-20.pdf
3.
UK and Dutch competition authorities have taken welcome steps to allow cooperation in the food supply chain. UK Notification available at -
http://www.legislation.gov.uk/uksi/2020/369/made
Share on Facebook
Share on Twitter
Share on LinkedIn
Member Introduction
Mark Heaphy
Wiggin and Dana LLP
Connecticut, USA
View Profile
Stephen A. Malley
Law Offices of Stephen A. Malley
California, USA
View Profile
Ted Scott
Secretariat International, Inc.
California, USA
View Profile
Carlos E. López López
Wolf Popper LLP.
New York, USA
View Profile
The Lawyer Network in numbers
0
+
Members Firms
0
+
Countries
0
+
Practice Areas
0
+
Member Firms
Total Staff